Evaluating the Impact of Age and Comorbidities on COVID-19 Outcomes and Healthcare Costs: A Comparative Analysis of Immunocompromised and General Populations in the United States (EON-US)
Abstract Introduction The COVID-19 public health emergency (PHE) ended in May 2023, but limited information exists on the continued risk of severe COVID-19 among the immunocompromised (IC) population and those with certain chronic medical conditions (CMCs). This study aimed to assess the risk of mod...
Saved in:
| Main Authors: | Corey Fang, Casey Dobie, Amita Ketkar, Monica Verduzco-Gutierrez, George Fadda, Claire Bocage, Chia Chen Jenny Teng, Raven Perez, Mark Brunk-Grady, Lisa Glasser, Christine Dube, Nadine Breslin, Vincent Willey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-06-01
|
| Series: | Infectious Diseases and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40121-025-01160-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary tuberculosis in the immunocompromised patients
by: Vukosav Danijela, et al.
Published: (2019-01-01) -
Fungal Sinusitis in Immunocompromised Hosts
by: Abdulkadir Küçükbayrak, et al.
Published: (2014-08-01) -
Kodamaea ohmeri: A rare yeast causing invasive infections in immunocompromised patients
by: Parul Singh, et al.
Published: (2024-04-01) -
Cycloferon in the Treatment of Immunocompromised Patients with Allergic Rhinitis
by: N. S. Tataurshchikova
Published: (2020-05-01) -
Multidrug-Resistant Bacteria in Immunocompromised Patients
by: Alexandru Duhaniuc, et al.
Published: (2024-08-01)